NASOPHARYNGEAL CARCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CARCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an immunotherapy boost standard treatment for a Head-and-Neck cancer?
Disease control OngoingThis phase 3 trial is testing whether adding the immunotherapy drug toripalimab to standard chemotherapy and radiation can improve outcomes for people with locally advanced nasopharyngeal carcinoma, a type of head-and-neck cancer. Participants will receive either toripalimab or a…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New cancer staging system put to the test in chinese patients
Knowledge-focused OngoingThis study looks at whether the newest version of the cancer staging system (TNM-9) accurately predicts outcomes for people with nasopharyngeal carcinoma in parts of China where the disease is less common. Researchers will review medical records from about 1,400 patients treated …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: Lirong Wu • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC